about
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis CIntra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)KASL clinical practice guidelines: management of hepatitis CChronic hepatitis C virus infection: Serum biomarkers in predicting liver damageThyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspectiveAcoustic radiation force impulse of the liverIndications of Liver Biopsy in the Era of Noninvasive Assessment of Liver FibrosisDiagnostic Accuracy of Real-Time Shear Wave Elastography for Staging of Liver Fibrosis: A Meta-Analysis.Quantitative comparison of transient elastography (TE), shear wave elastography (SWE) and liver biopsy results of patients with chronic liver disease.Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis C by EOB-MRI.Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients.Biomarkers of disease differentiation: HCV recurrence versus acute cellular rejection.Real time shear wave elastography in chronic liver diseases: accuracy for predicting liver fibrosis, in comparison with serum markers.Advanced MRI methods for assessment of chronic liver diseaseReal-time sono-elastography in the diagnosis of diffuse liver diseases.Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver diseaseCan serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers.Plasma gelsolin protein: a candidate biomarker for hepatitis B-associated liver cirrhosis identified by proteomic approach.The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.Diagnosis and treatment of chronic hepatitis C infection.Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infectionClinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection."Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C.Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexesValidation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinomaAssessment of disease progression in patients with transfusion-associated chronic hepatitis C using transient elastography.Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography.Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.Evaluation of the significance of pretreatment liver biopsy and baseline mental health disorder diagnosis on hepatitis C treatment completion rates at a veterans affairs medical center.Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosisComparison of liver biopsy and transient elastography based on clinical relevance.Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experiencePerformance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian childrenIron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patientsRole of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model.
P2860
Q24563264-6AE98872-5B4D-4A35-B84F-83D42EF5AECEQ24802436-911D2A4F-74E6-49B3-9110-EE858ED0B10EQ26752471-C14BDDA0-C37A-409F-8753-67B341C2F382Q26773289-4AC0FED4-BF3F-46EF-9835-3C7448AB293BQ26827517-DA59AF61-CB48-474C-A22C-1018BD6C6F91Q26853283-8B0B9256-D617-4E54-B688-1D9B5306D21FQ30368738-FC850FDD-9B6C-4DB8-867D-29FE5E72F943Q30384119-7346B316-84EC-4BEA-8F34-731E04F9BA59Q30403283-94504EDB-10A9-4E36-9012-CB00411D5D41Q30422199-9338B475-DF2E-4772-90A2-88BD0C3E7147Q30422395-7F71E9F7-69A9-4A84-8F81-445FE3687C0FQ30426477-FB01D0A6-462B-4EB1-9FB3-E9E232C69898Q30426512-B6AB05E7-E611-4FDD-8761-FCDEC1ECEDD9Q30428521-985C409A-1E30-4B11-86F1-740142398C57Q30478601-C812EA73-6097-4D4B-84A1-72A68A924537Q30482055-3419CF4F-9511-4651-86EB-C9A03795AA41Q33389011-11173E48-8385-45D5-844F-8275F0052744Q33565557-3FCD3C7C-41D4-4272-BAD9-C425520BAD3EQ33665359-D1901883-30CB-4BBB-87BF-143B05446E9BQ33867515-4AE52DB6-70F0-4D2C-86FB-E04AAE580F37Q33962464-009B55AD-01E9-48AA-88BE-ABA3728BF393Q33999294-1096379E-B97E-4103-8D43-0B51BE9882DBQ34574228-EF8A12F6-F61E-458E-967A-58815481B1E9Q34589232-EB2D2DED-55BD-46EB-BDC7-634C4226CAC8Q34873114-0A081018-4C03-47B9-B485-1B3DC8BAE597Q35544359-8330C158-0493-4FB2-BCF5-19FA416E131CQ35575885-A4285C8C-5B38-4636-BFEB-B9C45C8D2FDAQ35760270-9D3CD5FC-ABF7-486D-9ACB-1E40A53B3832Q35833021-0EEBDAC6-B90A-4CDE-8E93-26B4FEC77F65Q35872121-63D1423D-CCA9-4841-8111-80332DBE69EBQ36255455-E616A571-6403-4692-90AA-96F2FCE096B7Q36812170-D563DF77-745E-4B54-A772-EF4BA10895BCQ36896324-52F59920-175F-434D-A4B6-932C3A20343CQ36913249-341ABB0F-1B78-4A16-933A-63BB328A39D8Q37141294-E781B433-5363-406F-BB20-0F6FD176895BQ37552675-AFA94EF2-AE7B-4DE2-B1C9-A57826EF809BQ37675175-FA4AAD97-B3F5-4F17-87E5-4CA45A51D52DQ37741820-C355CE3A-8178-4CB6-8BF8-8285A00A50CBQ38708562-EAE161B1-7E5F-4D02-8B5F-2D079ACCB582Q40441364-42DF1699-30D5-483E-B575-CD5D9126A0BF
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The role of liver biopsy in chronic hepatitis C.
@ast
The role of liver biopsy in chronic hepatitis C.
@en
The role of liver biopsy in chronic hepatitis C.
@nl
type
label
The role of liver biopsy in chronic hepatitis C.
@ast
The role of liver biopsy in chronic hepatitis C.
@en
The role of liver biopsy in chronic hepatitis C.
@nl
prefLabel
The role of liver biopsy in chronic hepatitis C.
@ast
The role of liver biopsy in chronic hepatitis C.
@en
The role of liver biopsy in chronic hepatitis C.
@nl
P2860
P356
P1433
P1476
The role of liver biopsy in chronic hepatitis C
@en
P2093
Jules L Dienstag
P2860
P304
P356
10.1053/JHEP.2002.36381
P407
P433
P50
P577
2002-11-01T00:00:00Z